Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial — Silvia Lanfranconi (2022) | RDL Network
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford, Mahdi Mahdi, Helen Jeffers, Christine Mwasuku, Karolina Krassowska, Robin Fox, Ian Binnian, Victoria Glover, Stephen Bright, Christopher Butler, Jennifer Cane, Andreas Halner, Philippa C. Matthews, Louise Donnelly, Jodie L. Simpson, Jonathan Baker, Nabil T. Fadai, Stefan Peterson, Thomas Bengtsson, Peter J Barnes, Richard Russell, Mona Bafadhel
Thomas Yau, Joong‐Won Park, Richard S. Finn, Ann‐Lii Cheng, Philippe Mathurin, Julien Edeline, Masatoshi Kudo, James J. Harding, Philippe Merle, Olivier Rosmorduc, Lucjan Wyrwicz, Eckart Schott, Su Pin Choo, Robin Kate Kelley, Wolfgang Sieghart, Éric Assenat, Renata Zaucha, Junji Furuse, Ghassan K. Abou‐Alfa, Anthony B. El-Khoueiry, Ignacio Melero, Damir Begic,
David J. Werring, Hakim‐Moulay Dehbi, Norin Ahmed, Liz Arram, Jonathan G. Best, Maryam Balogun, Kate Bennett, Ekaterina Bordea, Emilia Caverly, Marisa Chau, David Cohen, Mairead Cullen, Caroline J Doré, Stefan T. Engelter, Robert Fenner, Gary A. Ford, Aneet Gill, Rachael Hunter, Martin James, Archana Jayanthi, Professor Gregory Lip, ,
William HK Schilling, Podjanee Jittamala, Phrutsamon Wongnak, James A Watson, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M. Batty, Ellen M. Beer, Shivani Singh, Tanatchakorn Asawasriworanan, Timothy Seers, Koukeo Phommasone, Terry John Evans, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Wanassanan Madmanee, Jindarat Kouhathong, Kanokon Suwannasin,
Discussion(0)
No comments yet. Be the first to comment.